Mel Mann: From Cancer Survivorship to Advocacy, A Call for Greater Lymphedema Awareness
Mel Mann/X

Mel Mann: From Cancer Survivorship to Advocacy, A Call for Greater Lymphedema Awareness

Mel Mann, Patient Advocate, Chronic Myeloid Leukemia Survivor, shared on X:

“Kathy Bates Beat Ovarian Cancer in Secret.

Then Faced Breast Cancer and Refused to Stay Silent.

Kathy Bates was diagnosed with ovarian cancer in 2003 and fought it largely in private. In 2012 breast cancer led her to choose a double mastectomy, and lymph node removal left her with lymphedema in both arms – she now advocates for lymphatic research.

Know ovarian cancer’s quiet signs:

  • bloating
  • pelvic pain
  • feeling full quickly
  • urinary urgency.

New cancer stories every day on YouTube.”

Proceed to the video attached to the post:

Mastectomy or Breast-Conserving Surgery for Recurrence

  • Mastectomy has historically been the preferred treatment for ipsilateral breast tumor recurrence after previous lumpectomy and whole-breast radiotherapy, mainly because of concerns about cumulative radiation-related tissue damage.
  • Comparative data showed five-year overall survival of 88% after mastectomy, versus 87% after repeat breast-conserving treatment, with no statistically significant difference between groups.
  • Repeat breast-conserving surgery with partial-breast reirradiation may offer an alternative to mastectomy for carefully selected patients, achieving favorable local control while preserving the breast.
  • Mastectomy remains an important option, particularly for patients with multifocal disease, positive surgical margins, early recurrence, extensive skin involvement, or substantial previous radiation-related toxicity.

You may also be interested in:

Mel Mann Highlights Sidney Farber’s Pioneering Role as the Pathologist Who Started Chemotherapy

William Hill: Tu-Stroma – A Blood-Based Biomarker for Early Ovarian Cancer Detection

Beyond Cancer Survival: New Study Links Chemotherapy to Accelerated Biological Aging in Breast Cancer